Загрузка...
Pharmacokinetics and pharmacodynamics of ropinirole in patients with prolactinomas
AIMS: Treatment of prolactinomas with ergoline dopamine agonists can be complicated by intolerance and resistance. This study investigated the pharmacokinetics and pharmacodynamics of the nonergot dopamine agonist ropinirole, to assess its therapeutic potential as a novel therapy for prolactinomas....
Сохранить в:
| Опубликовано в: : | Br J Clin Pharmacol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6339972/ https://ncbi.nlm.nih.gov/pubmed/30362146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13802 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|